Successful Pamidronate Treatment of Osteogenesis Imperfecta Type III Infant with Multiple Fractures.
10.6065/apem.2012.17.3.194
- Author:
Ju Hee YOON
1
;
Jong Uk BAEK
;
Eun Jung SHIM
;
Il Tae HWANG
Author Information
1. Department of Pediatrics, Hallym University College of Medicine, Seoul, Korea. ithwang83@hallym.or.kr
- Publication Type:Case Report
- Keywords:
Osteogenesis imperfecta;
Pamidronate;
Bone density;
Fractures, bone
- MeSH:
Bone Density;
Clavicle;
Congenital Abnormalities;
Connective Tissue;
Diphosphonates;
Female;
Femur;
Fractures, Bone;
Humans;
Infant;
Infant, Newborn;
Osteogenesis;
Osteogenesis Imperfecta;
Parturition;
Ribs;
Skull
- From:Annals of Pediatric Endocrinology & Metabolism
2012;17(3):194-197
- CountryRepublic of Korea
- Language:English
-
Abstract:
Osteogenesis imperfect (OI) is a generalized connective tissue disorder. We report the female neonate case with OI type III who showed severe bone deformities and fractures in utero. At birth, she showed multiple fractures in the clavicle, rib, femur, and wormian bone in the skull X-ray. We initiated pamidronate disodium infusion 30 mg/m2 in cycles of 3 consecutive days from when she was 4 days old, monthly for the first 3 months and every 2 months thereafter without adverse effects.
